(Q52027305)

20 April 2018

title

Predictive value of linear-quadratic model in the treatment of cervical cancer using high-dose-rate brachytherapy. (English)

1 reference

20 April 2018

1 reference

cervix uterine cancer

1 reference

Brij Sood

1

1 reference

20 April 2018

Madhur Garg

2

1 reference

20 April 2018

Jai Avadhani

3

1 reference

20 April 2018

Giridhar Gorla

4

1 reference

20 April 2018

Harish Malhotra

5

1 reference

20 April 2018

Chandan Guha

6

1 reference

20 April 2018

Shivaji Deore

7

1 reference

20 April 2018

Bhadrasain Vikram

8

1 reference

20 April 2018

language of work or name

English

0 references

publication date

1 December 2002

1 reference

20 April 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

20 April 2018

volume

54

1 reference

20 April 2018

issue

5

1 reference

20 April 2018

page(s)

1377-1387

1 reference

20 April 2018

High-dose-rate intracavitary irradiation in the treatment of carcinoma of the uterine cervix: Early experience with 84 patients

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

High-dose-rate remote afterloading intracavitary radiation therapy for cancer of the uterine cervix. A 20-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

Combined external and high dose rate intracavitary radiotherapy in the primary treatment of cancer of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

High-dose rate and low-dose rate intracavitary therapy for carcinoma of the uterine cervix. Final results of Osaka University Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

A comparison of the efficacy and complication rates of low dose-rate versus high dose-rate brachytherapy in the treatment of uterine cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

Multifractionated high-dose-rate brachytherapy with concomitant daily teletherapy for cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

Fractionated high dose rate versus low dose rate cervix cancer regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

Low dose rate vs. high dose rate brachytherapy in the treatment of carcinoma of the uterine cervix: a clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

Treatment of carcinoma of the uterine cervix by remotely controlled afterloading intracavitary radiotherapy with high-dose rate: a comparative study with a low-dose rate system

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: I. Clinical and radiobiological considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

High-dose-rate versus low-dose-rate intracavitary brachytherapy for carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

Dose fractionation, dose rate and iso-effect relationships for normal tissue responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

The linear-quadratic formula and progress in fractionated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

Patterns of radiotherapy practice for patients with squamous carcinoma of the uterine cervix: patterns of care study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

Optimizing radiation parameters for cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

Radiation therapy alone in the treatment of carcinoma of the uterine cervix. II. Analysis of complications

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

The hazard of accelerated tumor clonogen repopulation during radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

High-dose-rate brachytherapy for carcinoma of the cervix: high tech or high risk?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

Long term results of Cathetron high dose rate intracavitary radiotherapy in the treatment of carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: is there an optimal fractionation schedule?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: clinical experience with and without chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

The prediction of late rectal complications following the treatment of uterine cervical cancer by high-dose-rate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

Late rectal complication following high dose rate intracavitary brachytherapy in cancer of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

High-dose-rate afterloading brachytherapy in carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

Radiation therapy of cervical cancer with dosimetric prevention of late pelvic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903051-1

7 January 2021

10.1016/S0360-3016(02)03051-1

Identifiers

DOI

1 reference

20 April 2018

1 reference

20 April 2018